<SEC-DOCUMENT>0001104659-24-104669.txt : 20241001
<SEC-HEADER>0001104659-24-104669.hdr.sgml : 20241001
<ACCEPTANCE-DATETIME>20241001080610
ACCESSION NUMBER:		0001104659-24-104669
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241001
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241001
DATE AS OF CHANGE:		20241001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cytosorbents Corp
		CENTRAL INDEX KEY:			0001175151
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				980373793
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36792
		FILM NUMBER:		241341377

	BUSINESS ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		973-329-8885

	MAIL ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MedaSorb Technologies CORP
		DATE OF NAME CHANGE:	20060807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILDER ENTERPRISES INC
		DATE OF NAME CHANGE:	20020611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2425307d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ctso="http://cytosorbents.com/20241001">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_ctso_cytosorbents.com_20241001 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20241001_20241001 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001175151 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000004" name="dei:EntityCentralIndexKey">0001175151</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ctso-20241001.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-10-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90C_edei--DocumentType_c20241001__20241001_zL8xpopdlF0c"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase">Pursuant
to Section 13 or 15(</span>d<span style="text-transform: uppercase">)<br/>
of the Securities Exchange Act of 1934</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of Earliest Event Reported):
<span><span id="xdx_90D_edei--DocumentPeriodEndDate_c20241001__20241001_zHTESJyydur9"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October 1, 2024</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20241001__20241001_zGWZN1VPoaR5"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000011" name="dei:EntityRegistrantName">CYTOSORBENTS CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20241001__20241001_zTjPhwXZZO22"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityFileNumber_c20241001__20241001_zYPwKqSJKMNj"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000013" name="dei:EntityFileNumber">001-36792</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20241001__20241001_zbaNB0hX0GYa"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-0373793</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of<br/>
incorporation)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 50%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20241001__20241001_zS1LImpkTi4k"><b><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000015" name="dei:EntityAddressAddressLine1">305
        College Road East</ix:nonNumeric></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityAddressCityOrTown_c20241001__20241001_zMMA6giD6Ul"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000016" name="dei:EntityAddressCityOrTown">Princeton</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20241001__20241001_z8SlCexA7fy9"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">New Jersey</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; text-align: center; font-size: 10pt; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20241001__20241001_zK3kj5wR7DOc"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000018" name="dei:EntityAddressPostalZipCode">08540</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</span></td>
    <td style="text-align: center; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_904_edei--CityAreaCode_c20241001__20241001_z3EWFKOj0Yff"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000019" name="dei:CityAreaCode">732</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20241001__20241001_zp4zbVwnJ7O5"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000020" name="dei:LocalPhoneNumber">329-8885</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 100%; font-size: 10pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>
</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">(Former name or former address, if changed since last report.)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90A_edei--WrittenCommunications_c20241001__20241001_zCIhy0m1mOD2"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90D_edei--SolicitingMaterial_c20241001__20241001_zdtFtS8LZipl"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20241001__20241001_zlytZUX7AXb6"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top; text-align: justify">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20241001__20241001_zBX8jc1PZgqd"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border: black 1pt solid; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Name of each exchange on which <br/>
registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span id="xdx_901_edei--Security12bTitle_c20241001__20241001_z7zgvDRysZ2a" style="font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000025" name="dei:Security12bTitle">Common Stock, $0.001 par value</ix:nonNumeric></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20241001__20241001_ztaRU4xbeyi4"><ix:nonNumeric contextRef="AsOf2024-10-01" id="Fact000026" name="dei:TradingSymbol">CTSO</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center"><span style="font-size: 10pt">The <span id="xdx_900_edei--SecurityExchangeName_c20241001__20241001_zUp8Uke3eTlg"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC (Nasdaq Capital Market)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging Growth Company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20241001__20241001_z70ekUF6OdRl"><ix:nonNumeric contextRef="AsOf2024-10-01" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 10%; font-size: 10pt"><span style="font-size: 10pt"><b>&#160;Item 2.02</b></span></td>
    <td style="width: 90%; font-size: 10pt"><span style="font-size: 10pt"><b>Results of Operation and Financial Condition</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 1, 2024, CytoSorbents
Corporation (the &#8220;Company&#8221;) issued a press release announcing certain preliminary financial results for the quarter ended
September 30, 2024, including estimated ranges for quarterly product sales and product gross margins. A copy of the press release is furnished
herewith as Exhibit 99.1.*</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 10%; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Item 8.01</b></span></td>
    <td style="width: 90%; font-size: 10pt; text-align: justify"><span style="font-size: 10pt"><b>Other Events</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has submitted
its DrugSorb&#8482;-ATR medical device De Novo marketing application to the U.S. Food and Drug Administration (the &#8220;FDA&#8221;)
to reduce the severity of perioperative bleeding in patients on ticagrelor undergoing coronary artery bypass graft surgery. The FDA has
previously granted Breakthrough Device Designation to DrugSorb-ATR to address this major unmet medical need, making it eligible for priority
review. The Company has also completed its DrugSorb-ATR Health Canada Medical Device License application, which will be submitted with
the expected near-term receipt of Medical Device Single Audit Program certification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 10%; font-size: 10pt"><span style="font-size: 10pt"><b>&#160;Item 9.01</b></span></td>
    <td style="width: 90%; font-size: 10pt"><span style="font-size: 10pt"><b>Exhibits</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Exhibit No.</span></b></span></td>
    <td style="width: 90%; font-size: 10pt"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="tm2425307d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">99.1</span></a></td>
    <td style="font-size: 10pt"><a href="tm2425307d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Press Release of the Company, dated October 1, 2024</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt">104</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cover Page Interactive Data File (embedded with the Inline XBRL
document)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The information in Item 2.02 of this Form 8-K
shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">SIGNATURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: October 1, 2024</p></td>
    <td colspan="2"><span style="font-size: 10pt">CYTOSORBENTS CORPORATION</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; text-align: justify"><span style="font-size: 10pt">/s/ Dr. Phillip P. Chan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name: </span></td>
    <td><span style="font-size: 10pt">Dr. Phillip P. Chan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZi6axLuzSokWsIkXEbbBTCbaZMol/R/KWxhZxGBiG9773hBiJnFamQYbToizggG3XaI9QYo2M9ozBka03KYRb4sU4z9r6/v2BGQUGAzMbK6WD0FvvxmGVgkwmUk1UAnKaxnPYb0X01TOytanQeqMb0LaCPVPHBr3m15Bw0E+y1L76qiOyM2RTiMdykN+gZKxgR3f9IL46KIpMRKN+IpEz3brgWj492i8JywbbUOcG+r/RBwV6Sos= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2425307d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="tm2425307d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CytoSorbents
Submits DrugSorb&trade;-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on
the Blood Thinner Ticagrelor and Provides Business Update</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
                                            De Novo medical device application for DrugSorb&trade;-ATR is eligible for FDA priority review
                                            as an FDA Breakthrough Designated Device for this indication</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
                                            Health Canada Medical Device License application is ready for submission, pending the expected
                                            receipt of Medical Device Single Audit Program (MDSAP) certification in the near future</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Expecting
                                            FDA and Health Canada decisions in 2025</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">PRINCETON, N.J.,
October&nbsp;1, 2024 &mdash;&nbsp;</FONT><U>CytoSorbents Corporation</U> (NASDAQ: CTSO), a leader in the treatment of life-threatening
conditions in the intensive care unit and cardiac surgery using blood purification, announces the submission of its DrugSorb&trade;-ATR
medical device De Novo marketing application to the U.S. Food and Drug Administration (FDA) on September&nbsp;27, 2024, to reduce the
severity of perioperative bleeding in patients on ticagrelor (Brilinta&reg;, AstraZeneca) undergoing coronary artery bypass graft (CABG)
surgery. The FDA has previously granted Breakthrough Device Designation to DrugSorb-ATR to address this major unmet medical need, making
it eligible for priority review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The DrugSorb-ATR De Novo submission to
FDA is the culmination of multiple years of significant clinical, regulatory, and manufacturing accomplishments company-wide, centered
on the execution and data analysis from the U.S. and Canadian pivotal STAR-T randomized controlled trial and the product development
of DrugSorb-ATR,&rdquo; stated Dr.&nbsp;Phillip Chan, Chief Executive Officer. &ldquo;We are very proud of our dedicated CytoSorbents
team and external clinicians, collaborators, and consultants who helped to achieve this major milestone. We look forward to interactions
with FDA and the timely review of our application. Meanwhile, we have also completed our DrugSorb-ATR Health Canada Medical Device License
(MDL) application, which will be submitted with the expected near-term receipt of MDSAP certification.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ticagrelor is a blood thinning drug frequently
administered in the hospital to patients suffering from a heart attack. If patients are not eligible for a coronary stent, they will
often require CABG surgery to restore blood flow to heart muscle. Current guidelines recommend the delay of surgery by three to five
days to allow &ldquo;washout&rdquo; or natural elimination of the drug to reduce the high risk of serious and potentially fatal perioperative
bleeding from the use of the blood thinner. The 140 patient North American pivotal STAR-T randomized, double-blind, sham-controlled trial
evaluated the safety and efficacy of DrugSorb-ATR in patients undergoing urgent CABG surgery on ticagrelor to remove the drug and reduce
the severity of perioperative bleeding complications compared with patients operated without the device. These safety and efficacy data
from STAR-T form the basis of our marketing approval submissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About the U.S. and Canadian Regulatory Pathways</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.S. FDA De Novo process for medical devices
provides a marketing pathway to classify novel medical devices for which general controls alone, or general and special controls, provide
reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device. Following
application acceptance by FDA, De Novo submissions enter the substantive review phase where FDA Breakthrough Device designation and an
associated interactive priority review, called &ldquo;sprint discussions,&rdquo; can accelerate the process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Health Canada Medical Device License (MDL)
authorizes manufacturers to import or sell Class&nbsp;II,&nbsp;III, and IV medical devices in Canada. The license ensures that these
devices meet the necessary safety, quality, and efficacy standards as per the Medical Devices Regulations. MDL requires MDSAP certification,
which the Company expects to receive shortly, at which point it will file its MDL application.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Final regulatory decisions on DrugSorb-ATR are
expected from FDA and Health Canada in 2025. DrugSorb-ATR is not yet approved or cleared in the U.S. or Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preliminary, Selected Third Quarter Financial
Results and Business Update</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
                                            estimate that our Q3 2024 Product Sales (excluding grant income) will be in the range of
                                            approximately $8.3 million to $8.5 million, representing growth of 7% to 10%, versus $7.8
                                            million in Q3 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&bull;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
                                            planned temporary slowdown in production to rebalance inventory levels coupled with a short-term
                                            manufacturing issue resulted in a significantly lower number of CytoSorb devices produced
                                            in the quarter. Because of this, we estimate that our product gross margins for Q3 2024 will
                                            be in the range of approximately 50% - 60%, compared to 71% in Q3 2023. The Company believes
                                            the short-term manufacturing issue has been resolved and expects a return to more normalized
                                            production levels and product gross margins in Q4 2024. The Company continues to have sufficient
                                            inventory to meet demand.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About CytoSorbents Corporation (NASDAQ: CTSO)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><U>CytoSorbents
Corporation</U></FONT>&nbsp;is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery
through blood purification. CytoSorbents&rsquo; proprietary blood purification technologies are based on biocompatible, highly porous
polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Cartridges
filled with these beads can be used with standard blood pumps already in the hospital (e.g. dialysis, ECMO, heart-lung machines). CytoSorbents&rsquo;
technologies are used in a number of broad applications. Two important ones are 1) the removal of blood thinners during and after cardiothoracic
surgery to reduce the risk of severe bleeding and 2) the removal of inflammatory agents in common critical illnesses such as sepsis,
burn injury, trauma, lung injury, liver failure, cytokine release syndrome, and pancreatitis that can lead to massive inflammation, organ
failure and patient death. In these diseases, the risk of death can be extremely high, and there are few, if any, effective treatments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">CytoSorbents&rsquo;
lead product,&nbsp;</FONT><U>CytoSorb<SUP>&reg;</SUP></U>, is approved in the&nbsp;European Union&nbsp;and distributed in 76 countries
worldwide, with more than 250,000 devices used cumulatively to date. CytoSorb was originally launched in the&nbsp;European Union&nbsp;under
CE mark as the first cytokine adsorber. Additional CE mark extensions were granted for bilirubin and myoglobin removal in clinical conditions
such as liver disease and trauma, respectively, and for&nbsp;<U>ticagrelor</U>&nbsp;and&nbsp;<U>rivaroxaban</U>&nbsp;removal in cardiothoracic
surgery procedures. CytoSorb has also received&nbsp;<U>FDA Emergency Use Authorization</U>&nbsp;in&nbsp;the United States&nbsp;for use
in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. CytoSorb is not yet approved or cleared in&nbsp;the&nbsp;United
States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">In the U.S. and
Canada, CytoSorbents is developing the DrugSorb&trade;-ATR antithrombotic removal system, an investigational device based on an equivalent
polymer technology to CytoSorb, to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs. It
has received two&nbsp;</FONT><U>FDA Breakthrough Device Designations</U>: one for the removal of&nbsp;<U>ticagrelor</U>&nbsp;and another
for the removal of the&nbsp;<U>direct oral anticoagulants (DOAC) apixaban and rivaroxaban</U>&nbsp;in a cardiopulmonary bypass circuit
during urgent cardiothoracic procedures. In September&nbsp;2024, the Company submitted a De Novo medical device application to the U.S.
FDA requesting marketing approval to remove ticagrelor and reduce the severity of perioperative bleeding in CABG patients on the drug.
The Company expects to submit its completed Health Canada Medical Device License (MDL) application, pending the expected receipt of Medical
Device Single Audit Program (MDSAP) certification in the near future. DrugSorb-ATR is not yet approved or cleared in the United States
and Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company has
numerous marketed products and products under development based upon this unique blood purification technology protected by many issued&nbsp;U.S.&nbsp;and
international patents and registered trademarks, and multiple patent applications pending, including ECOS-300CY<SUP>&reg;</SUP>, CytoSorb-XL&trade;,
HemoDefend-RBC&trade;, HemoDefend-BGA&trade;, VetResQ<SUP>&reg;</SUP>, K<SUP>+</SUP>ontrol&trade;, DrugSorb&trade;, ContrastSorb, and
others. For more information, please visit the Company&rsquo;s websites at&nbsp;</FONT><U>www.cytosorbents.com</U>&nbsp;and&nbsp;<U>www.cytosorb.com</U>&nbsp;or
follow us on&nbsp;<U>Facebook</U>&nbsp;and&nbsp;<U>X</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This press
release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives,
future targets and outlooks for our business, representations and contentions, and the outcome of our regulatory submissions, and are
not historical facts and typically are identified by use of terms such as &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo;
 &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;predict,&rdquo;
 &ldquo;potential,&rdquo; &ldquo;continue&rdquo; and similar words, although some forward-looking statements are expressed differently.
You should be aware that the forward-looking statements in this press release represent management&rsquo;s current judgment and expectations,
but our actual results, events and performance could differ materially from those in the forward-looking statements. Factors which could
cause or contribute to such differences include, but are not limited to, the risks discussed in our Annual Report on Form&nbsp;10-K,
filed with the SEC on March&nbsp;14, 2024, as updated by the risks reported in our Quarterly Reports on Form&nbsp;10-Q, and in the press
releases and other communications to shareholders issued by us from time to time which attempt to advise interested parties of the risks
and factors which may affect our business. We caution you not to place undue reliance upon any such forward-looking statements. We undertake
no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or
otherwise, other than as required under the Federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B><U>Please Click to Follow Us on </U></B></FONT><B><U>Facebook
and X</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>U.S. Company Contact:<BR>
</B></FONT>Peter J. Mariani, Chief Financial Officer&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">305 College Road East&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Princeton, NJ 08540&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>pmariani@cytosorbents.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aman Patel, CFA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor Relations,&nbsp;ICR-Westwicke</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(443) 450-4191&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@cytosorbents.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ctso-20241001.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa6FCbOdzZR+mYkxtmB4bVmK/yYmkF3aNyT/tefmIe4A -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:ctso="http://cytosorbents.com/20241001" elementFormDefault="qualified" targetNamespace="http://cytosorbents.com/20241001">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://cytosorbents.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20241001_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20241001_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ctso-20241001_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ctso-20241001_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cytosorbents.com/role/Cover" xlink:href="ctso-20241001.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cytosorbents.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2425307d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2425307d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ": N4# 2(  A$! Q$!_\0
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD;...N?TH 6BF.V
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4Z].C[*4:L**BIS7)+FG4BE[RWO8#^L^7[HQCE@.1E<$$-N7*A@5)&&.,D$
ML%!_-/\ ;O\ ^"IG[/7_  3QU[X;>'OCAX:^+.MWGQ3TOQ5K/AQ_AOX<\/\
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M?M.PZA:OK7P?^!NK:6CN;FTTV/Q[HE_,6C=85AU6Z\6Z[:V9\]HQYESI-Y$
M?N*^R2/]7_V/?^"MGP#_ &H-;TKP#XFL;[X*?%?40(='\.^*=3L+WPSXMNM\
M0EM?!WC* 6\-YJ32M*]OH6L:;H>KWL$%T]C:ZI;6UW<VWHYSX9<:Y%A)XW&9
M+5EAZ;DJL\-6H8KV:BK\\X49SJ*G;7G4)V5G:UVN3+./.&LUK4<-0Q\:6(KT
MW.%#$Q=&HYWM&FE)V<I14I:M;629^M]%8U[<_8M.O;N-%=K2TGN A<QHS0Q&
M15<J'$22;!N(5C$I)VMN85_,4/\ @X$^)REL?LT^!'VO(JL/B-KJ*8O,8Q2
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M.VNMU?3;8^KUNTUIHT^Z>M_NMU8^BBBK **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH :V "3T!!_(@_P!*_G)_X.:-3EM?V'/A7HZ-MAU3]I?P6\N/72?
M_P 0KE><>DAQ].F*_HXK^;?_ (.</^3,?@M_V<EX=_\ 4!\?U]5P-KQ?P_Y9
ME'\,/C?Z^0'\/X/4$=%!5O56*R?^U :_I_\ ^#73_DX']K7/0_!_X;9^G_"8
M^(#_ /7K^8+LWX?^@Q5_3S_P:\''[0'[6GO\(?AJN 5#'/C'Q"#M+$8*KER5
M^;:K8!Z'^@^/]>#,X33G)X2HFTKN475PJ<>5M7LG=INSL]K@?'7_  <+_P#*
M3OQ]_P!D=^"__IHUJOQ* )SC&<9^;IQ@_P!*_O[_ &Y_^"&OP@_;J_:'UG]H
MKQA\>/BMX#UO7/"GA+PM+X<\):1X&O=#M[?PG;WT%K=6]QKF@WM^9;Q+]GG#
M2F,NF5[!?D!O^#7?]GE0?^,I_CWSP-V@?"]4!'S;W \*$,(]OFHCE5,J1DL"
M!GY3A_Q%X6R_(<KR_&XG$K$X+ X7"U*<<)*-*G.EHY\ZE+FC>6BY5=I:^]9/
M=_YZ'RIXE\$W?QG_ .#8_P"'NLM;0RWW[/\ XUD\9Z8P@NKF>/2/"_QT\6>#
M]2>UBMB(\_\ ")^--46_EOLV4&D?VA/(/,BA(_EK (W$#]XH1P!'U<1QI$$5
M?W6U9XBXNX/W=S8*MR>;85_I#>&O^">_A/X'?\$TOBI^PMX:\3:]\1=$U7X6
M?''1-+U_QA%!8ZKJ.N?$7_A*?$%DU_;^$+>QS!8>(M9MU6.SB\^>"U\@JR2M
M$?\ -VA$GD(EP9(YT3%WYH:WD21AMN5N8'^0R6S0R0+ O^D64L-U%/\ //7K
M>'>:87-8<5T</4JNA'B:KCL*XS=)_5L;ERJM>S:O'_:H2A)O>59MQ37*Q]/3
M^OZ\C^Y'_@V=\;V^L_L2?%+P)G3XKGX=?M#^*BL4=X)M1?3?%_A'P9XEMM0U
M"RQ_Q+[:XOY=6M]-E)_XF,.FRSKCRFS_ !E?'G5M-UWX]_';7M&N8[W2-;^.
M?QAUS2;V'[EWINM?$KQ+?Z?='_:N;>;[1C_;]<U_2'_P;*_%G3/">L?MN^"-
M=O=/L+"W\#_#SXPS02PW:ZRMAX4/C#0O$MUOF_T=].TBTU'0(W5/WAGU6WV8
M7?C^6Z\NH;_4=2U"T;SK;4-4OM1M"5V"6"\NY;B!F/<LSK(J]=Z*3G%/AS".
MAQOQW749TX8BKE]?#\C2]G]:G"M%2YHRC5<?9.;3@E-13LM+'0_7W_@@UX(7
MQI_P4[^"%S-IM[?V/@+PM\6O'TES:/*D6CW=EX)U3P]8:G?F,A#9_;_$MMIJ
M+<'R#?ZC99_>"('RG_@IW_P3]^*_["/Q=L+KXH>,?ASXLB_:#\2?%[XA>$8_
M $WB)Y=%TBR\;1:A+;>)4U_0M%1-0N(_&VG+#_9;7UF);+4/]((,9;]!O^#9
M3PG!K'[:7QJ\72W%W'/X,_9SN;.U@2'9#=MXT\?>$ENY+^3JUS$WAQ%@7O$9
M#C ./;O^#I#_ )*=^QG@' \!_&\D@_*"VO\ PN&/8G8<?0CM6-7-L5'Q6661
MK<^$GE-'"5J4J>']Z#PW]HJTHT4X-8INHW!J4KJ+E96#H?RM]B<$E<.H )#&
M-ED\OY1Y@DG"F"W,31O]JE@PX4L#^\7_  1C_P"":?QG_:+^(WP:_;2\(>.?
MACH_PV_9_P#VGM!C\6^&/$=WXHC\9:L? ,?A?QC?R>&UTOP]J^AL);+7;*+3
MTUK5+2-]1MI%GGBC+;OP=[-_NM_Z":_N5_X-EB!^PK\4LG&?VI_'(S[GX<?"
M8#'ODC'O7J^(N:XW*^%L9B<'4C#$U\30IU*LX1J1E0QT<9@YTG3EH^6GS/FO
MJY:*+BF(_,?_ (.5OVG_ !#XO_:%^'/[)VE:M-%X!^$_@K3/B1XQT>&[\FTU
MKXC_ ! ;48M 76[6*YE2\'AOP=9PSV-A?06^H6C^,+F]138ZO S?S/RR&)9)
M'81LL9=Y9-Z,K11,TK/'$PFB2+:$C2&.9Q&S/Y15&=/UK_X+FZO;:U_P5)_:
M9N+:%XEL4^%6C3F3 :2ZTKX2>"[6=E )^3*#'X5^1M[_ ,>ES_U[S_\ HF2O
M1X*P5'+^&.'\+0C[.-3+,)BJ[BH<]7&8B<I.M.4HR4HQE4;]E)2B]%S*RL,_
M7C]J;_@E/KG[+O[ O[/'[:VL_%,:OJWQFN_A];^)?A0/#5I90^"K3XI>&-;\
M7>'!H7B:'6;^YU>]LM/L[6TUJ.[L;"0WFHSNJ_N2I_(UD#ILD6)0T<B,)4DE
MMR4@5IOW4?S2[A(J7$72?<T)^^*_LC_X+$?\H-_V)O\ KY_8V_\ 5#^(J_C>
M7[B=/X.2,@8CC.3Z#C&??'>N7@;-L=G&3XK%YAB'7K1S[/L I3I8=Q^K8?%R
MP=.FU&C&5HQDVK232M&^\G7*W));W37FXM2M\^6WSOY']T'_  ;F_M7>-/CG
M^RSX]^"GQ U+5=?U;]F+Q3X?\.>%=>U>YEN[QOAAXRT[4;[P9X:N[V09N[GP
M7=Z#XBT.QER=OAN+PS9@ 6A)_G^_:8\+MX)_:/\ C]X1:PGTM?#WQE^)%E;V
M%P^Z:VTV;Q=JUYI"RC)_UNFS074)[QW#8SV^X_\ @UXN9E^/7[6=LLTJ6DGP
ME^&ET;43[K=KB/QCXDC6<18.V14ED7?QLC=^E?>__!83_@GKXY\4^+M0_:Q^
M!WAF_P#%+W.AP+\:O!VBQ176LPR^';.&ST_QYH6E?\?FN22:)'!IGBG2=*5;
M\6NC6&MJ9(7U%E\/A;-LLX1\4.(<LQ&(HX' 9[EN6NE5J35"AAL36K+,(QG5
MM/E5:5&IAX248Q]KB(J7+S'Y?XI9-B<VR; XG"4JU6IEV(KUZE/#I^VM5POU
M5RIM)M.FW&JWRN\5-:?$?SEZ)J][X>US0_$6FO&FI>'=:TG7].::-IH!?Z+J
M%OJ=F;B!"DEQ;K<6L;36L5S92W,:M;Q7ML\BR#^IZX\7_LE?\%H? OPR\$>)
MOB/XL^#GQ7^'>J:AXCU+X7:;J'AJS\3W.J7FAKINJRZ%/XATC6K#Q=X6$;W-
MS::CI%M;ZM"(H_[7M-(+-;2_RF*RN-RLK %E!02(I53M#!'&QD+!UC2/Y[,Q
MRP3_ +QQ5W3[V_TR_L=2TF_O])U73KRVOM,U72KV?3=3TV^M9DFM[S3]0M62
M[L;N%TS%=6DD5S 27BEC8;A^P<4\(4N(ZF QD,?CLDXBRN6)KY'FV%5.=.E0
MQ5&IR82O0YG3KJISNU6%90:GS-P:Y9?CF0\05,GJYCA,3AZ6/R_,?JKSC"8B
M4H*M]45G[+%J/,\0W&#]DJ.GLY+F=[K^J _\$"OV<SAF^-/QTW2.Q7]_X"(\
MR0('= _@DF(S+'"TL;"6$O&K-%N5=OZ-_L9_L;>!OV*? 'B?P!X"\4^,_%VG
M>*?&,_C>\O\ QE)HLFH1ZG)H>C:');0_V#I6@VI@:TT.S)22U&655+'&:_$W
M]@G_ (+,:[H-WX?^$?[7^I3:[X?NKC3](T#XYO&ZZOH"W,HM;:+XHJAA%_IB
M3"..;QI!%!=VT.;[7_[3B%S?VO\ 3=IU[:ZG:V>I:?=6]_IU_;6]Y8WUI<0W
M5I=V=TBSP75O<P3207,%U"Z3VTT&ZW:W97C<B3%?RIQ_B/$?+?\ A!XOS+,,
M1@ZT:->C.I4IU,'BOJDXRIN$HTU[TXIW@ZBJTK^\I)IR_<.#J'!>-IT,WX<P
ME##XFE'$T:L5[18BC/$OWW.$ZFL8/12<'&26G*]OXC_^"I?QXUWXX?MD_%&U
MNM2N)_"/PCU6X^%/@C3%NA-IMG;^&Y!%XIU2"*&XE@&HZ]XL&J37]\RB:]LK
M+1K;(73"#\ :)I%_XBUS0_#NE0M<:KXBUO1] TNWC3S))M2UK4[73=/BCB\^
MU\YWO+F +'Y\>X_Q"N]^../^%X_'#;C;_P +G^*WUW?\+"\3]?UZ\U+\!_\
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M*5*3B^9JI4RN#BI1TY5;[5_(Z^+[/+N"?B7_  @/ETW_ .%*>[OIHKGZ)_\
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MGEMW;@!-G3^/&1S7Y=2?ZN3_ '&_]!-?<>'_ /R2?"-XZ_V9D=G_ -NU=?\
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MM1K1A[].24GRP56G)))1ER734G:Q_I)PLIR0V24!XZ%2 R]1EF*,I+9(R,8
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MZ5EW ^+K<"XS):TXX?'8W&QS.G.I"T:-:+IRC1G[R=N53C[6ZMS)N&EG_G@
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M7EU.6&Q]5QI5'BZ2C73E""HR@H2C533EGGG!>>9!G+S' 8%8O T\QQ.-P5?
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M;GA=:77[M1=G=72LWJD]UL)>ZFJ<XK1[U+N[35TY3:OKU3(U8*0<99PS$G)
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MJ#ZTG=)V5WT7<:M?71=7:_X:#3+&!RZCW/3^8J)[J!1_K8A@\[F  X/0GO\
MTI7MXF&&W$'T/?!]!Z9JJ^F6[\_O!G'1L'\SCOSCUK.4JEGRP7-;2\K*_F[:
M%I4KKGG)1^U[FMO+WO0>=1LQ]ZZMP1U_>)Q_X_\ I4+:OIB_>O[9?<SH@_,N
M1[XZGKV-0-H-DY.?/!(_YZGZ=,G\?Y]*J2>%--?J9SD\XF9>/J#T]JQE+&)-
MQITW)+1.K=7_ / /4UC#+FTI5:J3W:I7M\G)7^]%QM>T5.NI62D=2+N#I_W\
MY_(<^E02>)_#R %]:L!SC#7EN.>3_?)S^E9C^!M&<\_:L]]MTX/XY_#]*IR?
M#K0')W?;?PO&!SZGU&.,?3L*PE5S3E?+1HWMI[_7U<5;[SHA1R5V=3$XE1O[
MW)AXRE;RC[57>VGXZ&P_BWPP@!;7-,49QEK^V4'VR6J%O&WA%.OB+1E/JVH6
MQX].'/IZ>O-<_)\*_"\N=PO^3GB_8=L>AJF_P=\(/DM_:8)SDKJ#YY[< <5C
M[7.^E"DWT3JI+YNSLOD=,,/PRVN;&9G%=7#+X*27=/ZQH_EW.F/C[P6#SXIT
M(>H-_:C'O][/YU _Q&\"*2&\6^'LCLVHVH Z_P!U@?S.,?A7)R? _P $R9W'
M6.?349!_G_&J4G[/_@*7.?[;R>NW4G'MWC?C\/H1T,3JY_ROEPN#YK:*IB/<
MOI\=J=U'?YV.F.&X137/F.>J/VG'!TN9+NDZS5]MUW.R;XG_  ]4X/C/PT"!
MR&U2W 'XF7KZ>O85 WQ7^&JG]YXY\+)CUUBT&#]6EQ^N:X:3]F_X=R_?77C]
M-4/T[VYJE)^R_P##*3.]/$ SW&KE?PXMQT["N=U>*$FXX/)6ULOK,M?_ "FS
M:.'X(YE?->)+7^S@L,WUV4JJ3?DVEYGH)^+_ ,+E)S\0/">1U!US3EQ[_-,H
M_7\*KO\ &GX3Q_>^(G@]3G&&U[3#_P"W..WK7F\G[*/PID^\OB3).?EUV1#Q
M[I;@D<],XS@]0*HO^R!\(9<[U\4#/=?$$K'Z8:W([YSU!Z<5C*OQ:T^7+\D<
MK:1EB:G*WIO:E>V^WD="PO ;:4\UXK4'\367X&Z7DOK2\CT]OCG\(5^]\2?!
M8^NO:4!^9N@/PJ!OCW\&!P_Q0\#)CGGQ%I:_JMU_]:O*Y/V,?@Q)DLOBPY/.
MW7Y%/YK;Y_#H>]47_8@^"$ISL\89SS_Q4<XX_"#./TK'VW&FZRKAU_\ <U77
MX^ST.B&"\-^:+EG'%ZC?5K+L!)I:_9EB^5^CT/7&_:"^!Z\-\6/ 8/?/B;2_
M_DOCMWJ(_M$_ A?O_%[X?KCJ&\4:8I'YW1_S]*\;E_80^!DWWH_&0YS\OB>Y
M4]^,^1TYZ?X51D_X)_? .7(=/&W_ (55U_\ (Y]:AU^-[.V4\.M_]AE;_P"0
M.M8/PONN;.^,U'JUE&5-KS2^LK\SVT_M)_L_KU^,?P[!'7=XLTG\>#<U"W[3
MG[/*?>^-'PV'U\6Z,/U>[4?KD]AC)'A<G_!.[]GF3JGCD$\G;XKNUZ>_V8G&
M3_GI6?)_P3?_ &<G)\Q?'G/]WQ==Y_6VZ#FLW7XY2?\ PD\.1\Y8S$)+S;5.
M32]$_0TA@O"=R7-G_''+?6V296WUVB\6D_1M>NA[XW[4O[.*GYOC=\-!['QA
MH/\ \G>WK4;?M6?LV)R?CC\,!V^;QEH/_P G&OGI_P#@FC^S1(<F/X@ ]\>,
M;M/U^S<Y[CO^%4I/^"8/[,4H^:/XA9/7'C6Z'KW^RGU]/Y5/UCCCIEW"U^C>
M.Q>__A,OS1T?4?!_[6?<?<O5QX?RAM+R7U_5GT8?VM/V90</\=?A6,>OC3P^
M/U-[CO4+?M??LNJ<-\?/A0I'KXW\._\ R:/YU\VO_P $LOV6Y"2T7Q%R>O\
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M!/\ T>#^SQ_X=7PA_P#+&C_AX]^P3_T>#^SQ_P"'5\(?_+&O@W_B'N_X)_\
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M/C3_ .'7O/\ Y4T?\0]W_!/_ /YX?&G_ ,.O>?\ RIH]KQU_T*>'?_"O$?\
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M>^'C_+434\?[9_[*#G _:(^$3\=!XZ\/>W]Z_([_ *U\E1_\$>/V/TX"_%'
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M9[2S"ODJH8:G*IF=#*:D*.95<+!^SC.&"JR<*\W4A3I\K<JEN:4/T9P?0_\
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M-KYKFU*^?:/_ +^?_7I0<]D_X"XS^N>*GHH]8P_\!?ZMK\ MY1_\G_\ DR'
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MW<,X/'UX_7-.HJ5%+77[V%EU2^X3(]1^8HR#T(/XTM%4%EV7W!1110,****
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MK1ESQC3DE*4:M249Q<;'YADG&]#CS+/&'*<SS["<(<3>(^?</\1Y=FV=5JF
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M@'XC:I9_!']I*.QB<65Q%>6D>G6^JW\B,$^W7OA*,W&FI)LBEU7X:Z1 YS<
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M''=1M%.-FK.4922:A*4'[C<%R\KCRR7*E=IV5!_F+!6)8#!*E1(6!SY?)X)
MQD9.1Q3D"L<MDL5.>074C:=C,!R<L#R.#P1D'%VBBSC?E;U:?[QNIRV_DO;E
MW>EVE?;>Z<+W3=X-N3@Z=))RE).4N:,%.[BG%---*3=V[,IN,YP5R"<$YQO
M&2>Q"+T_VL'D8IA4_,-P(5\<%E*#&!@J/O$\G\<U?HJF[I+:SNFDKJWPVNFD
MUK;1K78%!73DVWS<S<7R\TK**4DU).,(1C&G&2ER/FGJY:4L,5*_+U0(W+N=
MV2=Q8$CCIC'H,#-([QE=K$DD.0N<,ZQCD].!P3C)Z8SQ5ZBA.W>3NG>35W:W
M9+33962Z)=':2^&;B_WKYE&/.YSO[.3ERJZI-W4;>]97:13!68%%.,*!(0QW
MQDH"-IQU&<$?4'MAFQ5*85&8-@,3DN%&,LXP2^.@/&!WJ_10VW]J25[\J:2;
M\]+M7MI=:)==0Y5HFHSC?G:J1C/]XX1A*:]U<M[2:2::<M[)ITS'"SLQ!W.$
M5B6)&"0R_*>G3\NIZ4R6**11\H;!E^ZQ4EGC<,.1_$,C//S8//2K]%',U)23
M^'X?[K>DGI;XEI;IN[D^S2CR14(PE*HYQ47:<:JY:D7>3M[2G>%5I^^GIRV5
MJL:*FU@I !)&23@E%4D9Z'C\Q]33+A@C* 0N6.[)880@#*E<_.6"@ C 4L2!
MU%VBGS>]S-)Z;/7:_*_^W;NW7LUK>G"+5FYQ5T[TY*$O=<>35QFGRQA&&L9)
MQ6JOJJ>]$8!@BJV$!! #2%BNT\YZ#))Z]>AYC<)^[(!5=^XA,!0S D.S#D(H
M5@W0Y((SFM"BB+47>,4K_%K)WWLTFY)-7[=%L*,+--JFW&/+!\B32<)QFV[/
M6<Y0J7C&-G"UGS76?(RF$L)%4G $@^=0<]!G<>1WQGKV)-30* ^<C<4Y"EL'
M&W+$'@$Y!P .IP *M45+Z-*/,W:4Y*\G#7W8M6Y=;=UH]&V$8./*W.IS*"IS
M2J2]G-+6+]FTTI7;<FFG+1.U@HHHH+"BBB@ HHHH **** "BBB@ HHHH ***
<* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46074258535248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  01,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYTOSORBENTS CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001175151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0373793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">305
        College Road East<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">329-8885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CTSO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ Q$!!60=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #$0$%9
M, Y'L.X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " #$0$%9F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,1 05FA3N3?4@0
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M2P$"% ,4    " #$0$%9)!Z;HJT   #X 0  &@              @ &Z$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #$0$%999!Y
MDAD!  #/ P  $P              @ &?$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #I$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2425307d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cytosorbents.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ctso-20241001.xsd</File>
    <File>ctso-20241001_lab.xml</File>
    <File>ctso-20241001_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2425307d1_8k.htm">tm2425307d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2425307d1_8k.htm": {
   "nsprefix": "ctso",
   "nsuri": "http://cytosorbents.com/20241001",
   "dts": {
    "schema": {
     "local": [
      "ctso-20241001.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ctso-20241001_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctso-20241001_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2425307d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://cytosorbents.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-10-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2425307d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-10-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2425307d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cytosorbents.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-24-104669-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-104669-xbrl.zip
M4$L#!!0    ( ,1 05E)5NQS*P,  .\+   1    8W1S;RTR,#(T,3 P,2YX
M<V2U5MMRVC 0?>],_T'U:\86AB1M""23DJ'#E"0=2-(D+QUA+T2#+;F2'*!?
M7\DW+@8*M/63O#KG[*YV5W;C<AH&Z V$I)PU+=>I6 B8QWW*1DWKH6]?]5N=
MCH4N+]Z_0_II?+!MU*80^'5TS3V[PX;\'-V2$.KH"S 01'%QCAY)$!L+;],
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MM%+/B)55H-]4)2BOQ?;[Y?5-U_*3W*PWR;]6."5RRW\!4$L#!!0    ( ,1
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MBYOF^-H_>R>4S +'91IDV./PQ#L.,37MMV^AO%$P_KC']=QH(!2AD[VPF *
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M9Q>,FI6)+(Q==EE507<YE1%"+VMV%)D4RNWF*2L5?9+9LH=(HKHA<26@8+*
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M4XBD R4<#ZJ\@%3D'GOI&Q3^5N5<QM%@9HG89X$%7"-E4Y:!D$YSX A26*>
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MTYOT%SK_!U!+ 0(4 Q0    ( ,1 05E)5NQS*P,  .\+   1
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K;3(T,C4S,#=D,5]E>#DY+3$N:'1M4$L%!@     %  4 20$   -       $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>tm2425307d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ctso-20241001.xsd" xlink:type="simple"/>
    <context id="AsOf2024-10-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-10-01" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-10-01" id="Fact000004">0001175151</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-10-01" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-10-01" id="Fact000010">2024-10-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-10-01" id="Fact000011">CYTOSORBENTS CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-10-01" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-10-01" id="Fact000013">001-36792</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-10-01" id="Fact000014">98-0373793</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-10-01" id="Fact000015">305         College Road East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-10-01" id="Fact000016">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-10-01" id="Fact000017">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-10-01" id="Fact000018">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-10-01" id="Fact000019">732</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-10-01" id="Fact000020">329-8885</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-10-01" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-10-01" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-10-01" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-10-01" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-10-01" id="Fact000025">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-10-01" id="Fact000026">CTSO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-10-01" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-10-01" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
